Startup Dossier
AlgenScribe
Gene-editing biotech developing a versatile, patented platform combining synergistic molecular biology tools to correct pathogenic DNA mutations—from base editing of a few nucleotides to large gene replacement involving thousands of base pairs.
active
Typestartup
SectorBioTech
LocationNice
About
Gene-editing biotech developing a versatile, patented platform combining synergistic molecular biology tools to correct pathogenic DNA mutations—from base editing of a few nucleotides to large gene replacement involving thousands of base pairs.
Structural DNA
Legal Name
AlgenScribe
SIREN
922650718
Funding Lineage
Seed
0 investors
€470K
Dec 2025
Pre Seed
YES invest (Lead)
—
Jun 2023